Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:37 PM ET Form 4
Insider Selling Stoke Therapeutics, Inc. STOK

Stoke Therapeutics General Counsel & Corp Sec Jonathan Allan Sells $16.5K of Stock

Jonathan Allan, General Counsel & Corp Sec, sold 627 shares of Stoke Therapeutics, Inc. at $26.33 a share, worth $16.5K in total on Oct 2, 2026. Shares held after the trade: 20,598 (-3.0%).

Value
$16.5K
Shares
627
Price
$26.33
Role
General Counsel & Corp Sec
Holding change
-3.0%
Trade date
Oct 2, 2026
5:36 PM ET Form 4
Insider Selling Stoke Therapeutics, Inc. STOK

Stoke Therapeutics CMO Barry Ticho Sells $27.5K of Stock

Barry Ticho, CMO, sold 1,051 shares of Stoke Therapeutics, Inc. at $26.16 a share, worth $27.5K in total on Oct 1, 2026. Shares held after the trade: 19,059 (-5.2%).

Value
$27.5K
Shares
1,051
Price
$26.16
Role
CMO
Holding change
-5.2%
Trade date
Oct 1, 2026
5:34 PM ET Form 4
Insider Selling Walmart Inc. WMT

Walmart EVP Daniel J. Bartlett Sells $417K of Stock

Daniel J. Bartlett, EVP, sold 3,990 shares of Walmart Inc. at $104.41 a share, worth $417K in total on Oct 1, 2026. Shares held after the trade: 618,359 (-0.6%).

Value
$417K
Shares
3,990
Price
$104.41
Role
EVP
Holding change
-0.6%
Trade date
Oct 1, 2026
5:31 PM ET Form 4
Insider Selling Cardlytics, Inc. CDLX

Cardlytics CEO Amit Gupta Sells $46.7K of Stock

Amit Gupta, CEO, sold 17,733 shares of Cardlytics, Inc. at $2.53 to $2.71 a share (average $2.64) in 2 transactions, worth $46.7K in total between Oct 1, 2026 and Oct 2, 2026. Shares held after the trade: 138,906 (-5.0%).

Value
$46.7K
Shares
17,733
Average price
$2.64
Role
CEO
Holding change
-5.0%
Trade date
Oct 1, 2026 to Oct 2, 2026
5:29 PM ET 8-K
Shareholder Meeting Outdoor Holding Co POWW

Outdoor Holding Shareholder Meeting

Outdoor Holding Company held its 2026 Annual Meeting of Stockholders on September 28, 2026, where shareholders approved the redomestication of the company from Delaware to Texas. The conversion became effective on September 30, 2026, resulting in the company's internal affairs being governed by Texas law and the automatic conversion of outstanding common and preferred shares into shares of the new Texas corporation.

5:28 PM ET 8-K
Divestiture ChronoScale Holdings Corp CHRN

ChronoScale Holdings Divestiture

ChronoScale Holdings Corporation completed the sale of its wholly owned subsidiary, Ekso Bionics, Inc., to focus resources on its core AI infrastructure business. In connection with the divestiture, Ekso's COO Jason C. Jones was terminated and received a severance package totaling approximately $0.24 million. The company also announced new AI infrastructure contracts expected to drive an annualized revenue run rate of $1 billion by Q3 2027.

5:25 PM ET 8-K
Shareholder Meeting Richtech Robotics Inc. RR

Richtech Robotics Shareholder Meeting

Richtech Robotics Inc. held its 2026 Annual Meeting of Stockholders on September 29, 2026. Shareholders elected Saul Factor and John Shigley to the Board of Directors for three-year terms and ratified the appointment of CBIZ CPAs P.C. as the company's independent auditor.

5:21 PM ET Form 4
Insider Selling Nurix Therapeutics, Inc. NRIX

Nurix Therapeutics CLO Christine Ring Sells $134K of Stock

Christine Ring, CLO, sold 5,786 shares of Nurix Therapeutics, Inc. at $23.19 a share, worth $134K in total on Oct 2, 2026. Shares held after the trade: 9,110 (-38.8%).

Value
$134K
Shares
5,786
Price
$23.19
Role
CLO
Holding change
-38.8%
Trade date
Oct 2, 2026
5:20 PM ET 8-K
Court & Legal Update Tonix Pharmaceuticals Holding Corp. TNXP

Tonix Pharmaceuticals Holding Court & Legal Update

Tonix Pharmaceuticals received a Paragraph IV patent certification notice from Dr. Reddy’s Laboratories (DRL) regarding an Abbreviated New Drug Application (ANDA) for a generic version of TONMYA®. DRL claims that four of Tonix's Orange Book-listed patents are invalid, unenforceable, or not infringed. Tonix intends to vigorously enforce its intellectual property rights, which could trigger an automatic 30-month stay of FDA approval for the generic product.

Counterparty
Dr. Reddy’s Laboratories Ltd. and Dr. Reddy’s Laboratories, Inc.
5:20 PM ET 8-K
Nasdaq/NYSE Compliance Notice Healthcare Triangle, Inc. HCTI

Healthcare Triangle Nasdaq/NYSE Compliance Notice

Healthcare Triangle received a Staff Delisting Determination from Nasdaq on October 1, 2026, for failing to maintain the $1.00 minimum bid price requirement. Because the company has already effected cumulative reverse stock splits exceeding a 1-for-250 ratio over the last two years, it is ineligible for a standard 180-day compliance period. The company intends to appeal the delisting determination to a Nasdaq Hearings Panel, which will stay the suspension of its common stock pending a decision.

Counterparty
Nasdaq
5:20 PM ET Form 4
Insider Selling PTC Therapeutics, Inc. PTCT

PTC Therapeutics Director Glenn Steele Jr. Md. Phd. Sells $782K of Stock

Glenn Steele Jr. Md. Phd., Director, sold 12,000 shares of PTC Therapeutics, Inc. at $65.16 a share, worth $782K in total on Sep 30, 2026. Shares held after the trade: 22,500 (-34.8%).

Value
$782K
Shares
12,000
Price
$65.16
Role
Director
Holding change
-34.8%
Trade date
Sep 30, 2026
5:20 PM ET Form 4
Insider Selling Rocket Lab Corp RKLB

Rocket Lab CFO Adam C. Spice Sells $9.93M of Stock

Adam C. Spice, CFO, sold 140,157 shares of Rocket Lab Corp at $70.28 to $71.79 a share (average $70.82) in 3 transactions, worth $9.93M in total on Oct 1, 2026. Shares held after the trade: 1,155,967 (-1.3%).

Value
$9.93M
Shares
140,157
Average price
$70.82
Role
CFO
Holding change
-1.3%
Trade date
Oct 1, 2026
5:20 PM ET Form 4
Insider Selling Ceribell, Inc. CBLL

Ceribell CTO Raymond Woo Sells $119K of Stock

Raymond Woo, CTO, sold 4,887 shares of Ceribell, Inc. at $24.38 a share, worth $119K in total on Oct 1, 2026. Shares held after the trade: 203,118 (-2.3%).

Value
$119K
Shares
4,887
Price
$24.38
Role
CTO
Holding change
-2.3%
Trade date
Oct 1, 2026
5:19 PM ET Form 4
Insider Selling Oramed Pharmaceuticals Inc. ORMP

Oramed Pharmaceuticals CFO Avraham Gabay Sells $90.2K of Stock

Avraham Gabay, CFO, sold 20,000 shares of Oramed Pharmaceuticals Inc. at $4.51 a share, worth $90.2K in total on Oct 1, 2026. Shares held after the trade: 861,076 (-2.3%).

Value
$90.2K
Shares
20,000
Price
$4.51
Role
CFO
Holding change
-2.3%
Trade date
Oct 1, 2026
5:19 PM ET Form 4
Insider Selling Oramed Pharmaceuticals Inc. ORMP

Oramed Pharmaceuticals COO & Cbo Joshua Hexter Sells $135K of Stock

Joshua Hexter, COO & Cbo, sold 30,000 shares of Oramed Pharmaceuticals Inc. at $4.51 a share, worth $135K in total on Oct 1, 2026. Shares held after the trade: 1,328,130 (-2.2%).

Value
$135K
Shares
30,000
Price
$4.51
Role
COO & Cbo
Holding change
-2.2%
Trade date
Oct 1, 2026
5:19 PM ET Form 4
Insider Buying AMG BBH Asset-Backed Credit Fund, LLC BBASX

AMG BBH Asset-Backed Credit Fund Insider Neil Martin Hohmann Buys $90K of Stock

Neil Martin Hohmann bought 9,020 shares of AMG BBH Asset-Backed Credit Fund, LLC at $9.98 a share, worth $90K in total on Jul 1, 2026. Shares held after the trade: 4,510.

Value
$90K
Shares
9,020
Average price
$9.98
Trade date
Jul 1, 2026
5:18 PM ET 8-K
Other 8-K Filing Planet Green Holdings Corp. PLAG

Planet Green Holdings Other 8-K Filing

Planet Green Holdings Corp. entered into an ATM Sales Agreement with Craft Capital Management LLC to establish an at-the-market offering program. Under the agreement, the company may sell up to approximately $22.54 million of its common stock from time to time, though no shares have been sold as of the filing date.

Counterparty
Craft Capital Management LLC
5:16 PM ET Form 4
Insider Selling Verastem, Inc. VSTM

Verastem President and CEO Dan Paterson Sells $353K of Stock

Dan Paterson, President and CEO, sold 44,121 shares of Verastem, Inc. at $8.00 a share, worth $353K in total on Oct 1, 2026. Shares held after the trade: 652,712 (-6.3%).

Value
$353K
Shares
44,121
Price
$8.00
Role
President and CEO
Holding change
-6.3%
Trade date
Oct 1, 2026
5:15 PM ET 8-K
Loan & Debt HeartSciences Inc. HSCS

HeartSciences $500K Debt Financing with Front Range Ventures LLC

HeartSciences Inc. entered into Amendment No. 8 to its loan agreement with Front Range Ventures LLC to extend the maturity date of a $500,000 secured promissory note. The new maturity date is the earlier of January 29, 2027, or two business days following the closing of its proposed business combination with Fortitude Mining Holdings, Inc.

Value
$500K
Counterparty
Front Range Ventures LLC
Term
through Jan 2027
5:15 PM ET 8-K
Reverse Stock Split GEE Group Inc. JOB

GEE Group Reverse Stock Split

GEE Group stockholders approved a 1-for-30 reverse stock split at the 2026 Annual Meeting. The meeting was adjourned to October 8, 2026, to continue soliciting votes for a separate proposal to increase authorized common shares from approximately 6.67 million to 200 million. Other approved items included the election of two Class I directors and the ratification of Cherry Bekaert LLP as auditors.

5:15 PM ET Form 4
Insider Selling Verastem, Inc. VSTM

Verastem CFO Daniel Calkins Sells $20.5K of Stock

Daniel Calkins, CFO, sold 2,566 shares of Verastem, Inc. at $8.00 a share, worth $20.5K in total on Oct 1, 2026. Shares held after the trade: 123,781 (-2.0%).

Value
$20.5K
Shares
2,566
Price
$8.00
Role
CFO
Holding change
-2.0%
Trade date
Oct 1, 2026
5:14 PM ET 8-K
Shareholder Meeting Sobr Safe, Inc. SOBR

Sobr Safe Shareholder Meeting

SOBR Safe, Inc. announced the postponement of its 2026 Annual General Meeting of Stockholders, which was previously scheduled for November 2, 2026. The company also clarified that while it is exploring strategic options, no decision has been made to dissolve the company despite ceasing its primary operations. The stock recently transitioned to trading on the OTC Pink market following a delisting from Nasdaq.

5:14 PM ET Form 4
Insider Selling Coursera, Inc. COUR

Coursera President & CEO Gregory M. Hart Sells $52.6K of Stock

Gregory M. Hart, President & CEO, sold 10,308 shares of Coursera, Inc. at $5.11 a share, worth $52.6K in total on Oct 1, 2026. Shares held after the trade: 1,539,003 (-0.7%).

Value
$52.6K
Shares
10,308
Price
$5.11
Role
President & CEO
Holding change
-0.7%
Trade date
Oct 1, 2026
5:13 PM ET Form 4
Insider Selling Generac Holdings Inc. GNRC

Generac Holdings CEO Aaron Jagdfeld Sells $1.03M of Stock

Aaron Jagdfeld, CEO, sold 5,000 shares of Generac Holdings Inc. at $206.00 a share, worth $1.03M in total on Oct 1, 2026. Shares held after the trade: 544,528 (-0.9%).

Value
$1.03M
Shares
5,000
Price
$206.00
Role
CEO
Holding change
-0.9%
Trade date
Oct 1, 2026
5:10 PM ET 8-K
Executive Compensation Pinterest, Inc. PINS

Pinterest Executive Compensation

Pinterest, Inc. amended and restated its Severance and Change in Control Plan for Level 21 employees to include pro-rated target annual bonuses for terminations without cause. The updated plan also provides for enhanced bonus payouts during change-in-control events and clarifies that a reduction of more than 10% in target annual bonus constitutes 'good reason' for termination.

5:10 PM ET Form 4
Insider Selling Warby Parker Inc. WRBY

Warby Parker Insider Jeffrey Jacob Raider Sells $416K of Stock

Jeffrey Jacob Raider sold 15,000 shares of Warby Parker Inc. at $27.70 a share, worth $416K in total on Oct 1, 2026. Shares held after the trade: 420,201 (-3.4%).

Value
$416K
Shares
15,000
Price
$27.70
Holding change
-3.4%
Trade date
Oct 1, 2026
5:09 PM ET Form 4
Insider Selling Warby Parker Inc. WRBY

Warby Parker Co-CEO Neil Harris Blumenthal Sells $2.77M of Stock

Neil Harris Blumenthal, Co-CEO, sold 100,000 shares of Warby Parker Inc. at $27.69 a share, worth $2.77M in total on Oct 1, 2026. Shares held after the trade: 36,020 (-73.5%).

Value
$2.77M
Shares
100,000
Price
$27.69
Role
Co-CEO
Holding change
-73.5%
Trade date
Oct 1, 2026
5:06 PM ET 8-K
Stock Plan Amendment Live Nation Entertainment, Inc. LYV

Live Nation Entertainment Stock Plan Amendment

Live Nation entered into an amended and restated employment agreement with CEO Michael Rapino, extending his term through 2031. The agreement introduces significant new equity components, including annual $15 million time-based RSU grants and $15 million performance-based PSU grants starting in 2027, while maintaining his $3 million base salary and $17 million target cash bonus.

Term
through Dec 2031
5:06 PM ET 8-K/A
Executive Compensation Teledyne Technologies Inc TDY

Teledyne Technologies Executive Compensation

Teledyne Technologies entered into a separation agreement with Vice Chairman Jason VanWees regarding his retirement effective February 1, 2027. Mr. VanWees will serve as a strategic advisor through May 3, 2027, receiving his regular base salary and a final lump sum payment of $170,000 in exchange for cooperation and non-solicitation agreements.

Counterparty
Jason VanWees
Term
through May 3, 2027

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.